跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TACROLIMUS SANDOZ CAPSULE 0.5 MG - HSA Drug Approval Details
Approvals
/
HSA
/
TACROLIMUS SANDOZ CAPSULE 0.5 MG
Approved
THERAPEUTIC
TACROLIMUS SANDOZ CAPSULE 0.5 MG
Sandoz Private Limited
🇸🇬 Health Sciences Authority
Approval Date
Apr 25, 2019
Approval ID
dc2a5c33b4ac7cd8
Company
Sandoz Private Limited
Type
Therapeutic
Approval Details
Approval Id
dc2a5c33b4ac7cd8
Drug Name
TACROLIMUS SANDOZ CAPSULE 0.5 MG
Product Name
TACROLIMUS SANDOZ CAPSULE 0.5 MG
Approval Number
SIN15673P
Approval Date
2019-04-25
Registrant
NOVARTIS (SINGAPORE) PTE LTD
Licence Holder
SANDOZ SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
CAPSULE, GELATIN COATED
Route Of Administration
ORAL
Atc Code
L04AD02
Atc Item Name
tacrolimus
Pharma Manufacturer Name
SANDOZ SINGAPORE PTE. LTD.
Company Detail Path
/organization/sandoz-singapore-pte-ltd
Active Ingredients
Tacrolimus monohydrate 0.511mg equivalent to Tacrolimus
0.5 mg
TACROLIMUS MONOHYDRATE 0.511 MG EQUIVALENT TO TACROLIMUS
0.5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 25, 2019
Approval ID
dc2a5c33b4ac7cd8
Type
Therapeutic
Back to HSA Approvals